First Ebola Vaccine Granted Conditional Approval

The European Commission has approved the first Ebola vaccine, Servo, which is 97.5% effective for adults. Ebola symptoms include fever and hemorrhaging, spreading through bodily fluids. The virus has killed over 13,000 in Africa since 2013. Merck's CEO highlights the vaccine's development as a global scientific milestone. Over 250,000 doses are used in the Congo's current outbreak, with over 3,000 cases and 2,100 deaths, marking it as the largest outbreak since 2013-2016.

What did Kenneth Frazier, Merck CEO, say about the European Commission's marketing authorization of the Ebola vaccine?

How many confirmed cases of Ebola were there in the Democratic Republic of Congo as of Tuesday?